IFNG and multiple sclerosis: Increased serum levels of IFN-γ were reported in patients suffering from systemic lupus erythematous, inflammatory bowel diseases, multiple sclerosis, and rheumatoid arthritis (Ito et al. 2006; Rauch et al. 2013; Majoros et al. 2017).